Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > RT20 for Sale > RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - large image1
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - image1
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - image2
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - image3
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - image4
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - image5
RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver buy - image6

RT5 RT10 RT15 RT20 RT60 RT10099% purity Cagrilintide Peptides Weight Loss Peptide 10mg 15mg 30mg Fast deliver

2 Inquiries

Unit Price:

$10-13/G FOB

Get Latest Price
CAS No.:

232544-43-3

Content:

99%

Port:

SHENZHEN

Packaging:

10vial /box

Price valid (until):

2027-02-25

Company Type:
Trader
Location:
China
Qualification:
Main Products:

peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Pls input...Hangzhou Zhongshuan Technology Co., Ltd. is a full-spectrum enterprise combining R&D, production and sales services. Our core business lies in the manufacture and trade of various peptide products and chemical raw materials.
    We rank among China’s primary peptide suppliers with self-owned production premises. Following our development strategy that puts quality in the first place and leverages technological strengths, we dedicate ourselves to offering customers high-grade raw materials and professional solutions with cost-effective pricing.
    The zhongshuan peptide series is a high-quality product designed to meet the needs of companies to improve product efficacy, simplify production processes and gain competitive advantages in the pharmaceutical, cosmeceutical and nutraceutical markets. The product offers a range of features and benefits that make it ideal for businesses of all sizes, from small research labs to large manufacturing enterprises.
    Cagrelinide is a a cyclic peptide composed of 38 amino acids, with a sequence containing 38 amino acids and a pair of disulfide bonds. Kaglirin can significantly reduce weight and reduce food intake. Kagrelin peptide has potential in obesity research.
    As a non selective amino acid receptor (AMYR) and calcium G protein coupled receptor (CTR) advocate, Cagrinide is a new long acting acetylated amino acid analysis, which is a cyclic peptide composed of 38 amino acids The sequence contains a pair of defective bonds Cagritide can significantly reduce weight and food intake Cagritide has potential in objectivity research.

    Items Specifications






    Basic Info
    Product Name:

    RT20

    CAS No.:

    232544-43-3

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Room A0693, 6th Floor, Building 3, No.5 Lvtai Road, Zhongtai Subdistrict, Yuhang District, Hangzhou City, Zhejiang Province

    Average lead Time:

    15

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2025

    Certifications:

    TR60 COA

    Hangzhou ZhongShuan Technology Co., Ltd. specializes in the R&D and manufacturing of pharmaceutical-grade and healthcare-grade bioactive raw materials and their derivatives, which are widely used in pharmaceuticals, nutraceuticals and cosmetics industries and have gained global recognition for superior bioactivity and safety. Our 100,000-square-meter factory is built in strict compliance with GMP standards, boasting a clean production environment, scientific layout, and complete R&D and manufacturing facilities for deep processing of bioactive raw materials and solvent purification, laying a solid foundation for product quality. We are committed to providing global customers with high-quality products and customized professional solutions, and strive to drive product upgrading across various industries through in-depth cultivation of biotechnology.

    Global Market Reach
    The company's products, with their outstanding quality and stable performance, are exported to over, including the Middle East, South America, North America, Southeast Asia, Africa, Europe, etc., and have accumulated a good reputation in overseas markets. Relying on our professional team and global resource integration capabilities, we fully leverage our geographical and supply chain advantages, continuously optimize localized operations, and effectively help customers reduce costs and improve efficiency while ensuring high-quality products.

    Engaged in Raw Materials for 10+ Years
    We are a biotech enterprise engaged in the R&D, production, and sales of peptides and raw materials for more than 10 years.  The company has complete experimental facilities. Advanced testing instruments ensure the stability of product quality from all aspects. If you're interested in our products, don't hesitate to contact us.

  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Canada

    RT20

    200 MG Aug 13, 2026
    Australia

    Rt20

    10 G Jul 28, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.